Search company, investor...

Founded Year

2006

Stage

Corporate Majority | Acquired

Valuation

$0000 

About Granulab

Granulab is a medical device manufacturing company for synthetic bone graft GranuMas. On January 5th, 2021, KPower acquired a majority stake in Granulab.36M.

Headquarters Location

14, Jln Anggerik Mokara 31/47 Kota Kemuning

Shah Alam, 40460,

Malaysia

+603 5124 9622

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Latest Granulab News

Hydroxyapatite Market 2019 Precise Outlook - • Granulab (M) Sdn Bhd. , Cam Bioceramics, Zimmer Biomet, Aps Materials

Mar 30, 2023

News Provided By Share This Article Hydroxyapatite Market to Garner $3.65 Bn, Globally, By 2030 at 5.1% CAGR PORTLAND, OREGON, UNITED STATES, March 30, 2023 / EINPresswire.com / -- Allied Market Research published a report, titled, "Hydroxyapatite Market by Type (Nano-sized, Micro-sized, and Greater than Micrometer) and Application (Orthopedic, Dental Care, Plastic Surgery, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027." According to the report, the global hydroxyapatite industry was estimated at $2.46 billion in 2019, and is anticipated to hit $3.65 billion by 2027, registering a CAGR of 5.1% from 2020 to 2027. Drivers, restraints, and opportunities- Increase in demand for bone transplants and bone grafting, rise in disposable income, and advancements in R&D fuel the growth of the global hydroxyapatite market. On the other hand, high cost of implants restrains the growth to some extent. However, innovations in product development are expected to create multiple opportunities in the industry. Get Detailed COVID-19 Impact Analysis on the Hydroxyapatite Market @ https://www.alliedmarketresearch.com/request-for-customization/5106?reqfor=covid COVID-19 impact- • The COVID-19 outbreak has significantly impacted the global hydroxyapatite market. Dental practices all over the world are only seeing emergency patients, which has resulted in unprecedented revenue declines across the sector. • Moreover, disruptions in the supply chain have resulted into downswing in the manufacturing of orthopedic implants and dental care products. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5106 The micro-sized segment to dominate by 2027- Based on type, the micro-sized segment contributed to more than half of the global hydroxyapatite market share in 2019, and is expected to lead the trail by the end of 2027, owing to the mounting demand for prosthetic surgeries and dental surgeries. The nano-sized segment, on the other hand, would register the fastest CAGR of 5.5% till 2027. This is due to the presence of its unique properties, such as the ability to chemically bond with bones and form no toxicity or inflammation after implants. The orthopedic segment to maintain the dominant share- Based on application, the orthopedic segment accounted for around two-fifths of the global hydroxyapatite market revenue in 2019, and is expected to retain its dominance by 2027. This is attributed to the increasing demand for hydroxyapatite in medical device coating for knee and hip surgeries. Simultaneously, the plastic surgery segment would grow at the fastest CAGR of 5.6% throughout the forecast period, owing to increasing demand for hydroxyapatite in facial plastic surgeries. For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5106 North America garnered the major share in 2019 – Based on geography, North America generated the major share in 2019, holding around two-fifths of the global hydroxyapatite market. This is attributed to rise in demand for hydroxyapatite in ocular implants, non-integrated implants, and dental surgeries in countries such as the U.S. and Canada. At the same time, the Asia-Pacific region is projected to manifest the fastest CAGR of 5.5% during the study period. This is due to increase in disposable income of people in emerging countries, such as China and India, and new investments across Japan and China in advanced coating and material manufacturing. Key players in the industry- • Sofsera Interested in Procuring this Report? visit: https://www.alliedmarketresearch.com/hydroxyapatite-market/purchase-options About Us: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. David Correa

Granulab Frequently Asked Questions (FAQ)

  • When was Granulab founded?

    Granulab was founded in 2006.

  • Where is Granulab's headquarters?

    Granulab's headquarters is located at 14, Jln Anggerik Mokara 31/47 Kota Kemuning, Shah Alam.

  • What is Granulab's latest funding round?

    Granulab's latest funding round is Corporate Majority.

  • Who are the investors of Granulab?

    Investors of Granulab include Kumpulan Powernet Berhad.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.